EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023


Earnings Per Share
	For the three months ended September 30				For the nine months ended September 30
(In millions, except per share amounts)	2023		2022		2023		2022
Numerator:
Net income from continuing operations	$	386	$	493	$	1,202	$	1,382
Net (income) loss attributable to noncontrolling interests	(7)		(6)		(33)		(32)
Net income from continuing operations attributable to GE HealthCare	379		487		1,169		1,350
Deemed preferred stock dividend of redeemable noncontrolling interest	—		—		(183)		—
Net income from continuing operations attributable to GE HealthCare common stockholders	379		487		986		1,350
Income (loss) from discontinued operations, net of taxes	(4)		—		(4)		12
Net income attributable to GE HealthCare common stockholders	$	375	$	487	$	982	$	1,362
Denominator:
Basic weighted-average shares outstanding	455		454		455		454
Dilutive effect of common stock equivalents	3		—		3		—
Diluted weighted-average shares outstanding	458		454		458		454
Basic Earnings Per Share:
Continuing operations	$	0.83	$	1.07	$	2.17	$	2.97
Discontinued operations	(0.01)		—		(0.01)		0.03
Attributable to GE HealthCare common stockholders	0.82		1.07		2.16		3.00
Diluted Earnings Per Share:
Continuing operations	$	0.83	$	1.07	$	2.16	$	2.97
Discontinued operations	(0.01)		—		(0.01)		0.03
Attributable to GE HealthCare common stockholders	0.82		1.07		2.15		3.00
Antidilutive securities(1)	4		—		4		—

(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.